Federation des caisses Desjardins du Quebec’s Clementia Pharmaceuticals Inc. CMTA Stock Holding History

Federation des caisses Desjardins du Quebec’s Portfolio CMTA Stock Details CMTA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-500	Closed	-$13.1K	–	2374
2019 Q1	$13.1K	Hold	500	–	–	﹤0.01%	1604
2018 Q4	$5.88K	Sell	500 -1,000	-67%	-$12.4K	﹤0.01%	1738
2018 Q3	$16.7K	Hold	1,500	–	–	﹤0.01%	1600
2018 Q2	$19.7K	Buy	1,500 +1,000	+200%	+$16.2K	﹤0.01%	1571
2018 Q1	$7.58K	Sell	500 -500	-50%	-$8.13K	﹤0.01%	1778
2017 Q4	$19K	Hold	1,000	–	–	﹤0.01%	1582
2017 Q3	$16.9K	Buy	+1,000	New	+$16.3K	﹤0.01%	1564

Federation des caisses Desjardins du Quebec's CMTA Position: Q2 2019 in Review

Federation des caisses Desjardins du Quebec sold out of Clementia Pharmaceuticals Inc. (CMTA) in Q2 2019, closing a stake of 500 shares — an estimated $13.1K sold.

Federation des caisses Desjardins du Quebec first reported a position in CMTA in Q3 2017 and held it in 7 quarters. The position peaked at $19.7K in Q2 2018. 0 funds tracked by Wall St. Rank hold CMTA as of Q2 2019.

Federation des caisses Desjardins du Quebec reported no remaining Clementia Pharmaceuticals Inc. position as of Q2 2019 after selling out during the quarter.
Federation des caisses Desjardins du Quebec sold 500 Clementia Pharmaceuticals Inc. shares in Q2 2019, an estimated $13.1K.
Federation des caisses Desjardins du Quebec first reported a position in Clementia Pharmaceuticals Inc. in Q3 2017 and held it in 7 quarters.
Federation des caisses Desjardins du Quebec's Clementia Pharmaceuticals Inc. position peaked at $19.7K in Q2 2018.
0 funds tracked by Wall St. Rank held Clementia Pharmaceuticals Inc. as of Q2 2019.

Based on Federation des caisses Desjardins du Quebec's 13F filing for Q2 2019, filed 30 Aug 2024.